| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $721K | -85.4% |
| Cost of Revenue | $1.0M | -50.1% |
| Gross Profit | $2.9M | +1.1% |
| R&D Expense | $202K | +100.6% |
| SG&A Expense | $2.1M | +16.4% |
| Operating Income | -$3.3M | -241.7% |
| Pre-tax Income | -$3.3M | -232.7% |
| Net Income | -$3.3M | -232.7% |
| EPS (Basic) | -$0.37 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | -49.1% |
| Accounts Receivable | $816K | -39.4% |
| Inventory | $2.2M | +32.1% |
| Current Assets | $9.3M | -38.9% |
| Total Assets | $15.1M | -23.2% |
| Current Liabilities | $1.0M | -39.9% |
| Total Liabilities | $1.2M | -45.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.5M | -642.3% |
| Capital Expenditures | $77K | — |
| Investing Cash Flow | -$485K | -962.0% |
| Financing Cash Flow | -$25K | -100.2% |
| Free Cash Flow | -$5.5M | -652.7% |
| -105.6% |
| EPS (Diluted) | -$0.37 | -105.6% |
| Stockholders' Equity |
| $13.9M |
| -20.4% |